Ensure Successful Viral Clearance: A 10-Year Data Review Of Viral Clearance Unit Operations Efficacy And Emerging Technology

Ensuring consistent and reliable viral clearance remains a core requirement for safe biopharmaceutical production, even as downstream processes continue to evolve. This webinar brings forward a decade of viral clearance data to help teams understand which unit operations consistently deliver strong log reduction values and where emerging technologies may shift expectations.

The session examines the performance of established steps such as low‑pH treatment and chromatography, alongside newer approaches including Triton X‑100 alternatives and membrane‑based solutions. By comparing their respective viral reduction capabilities, attendees gain a clearer view of how to maintain effective safeguards while adapting workflows to regulatory and supply‑chain realities.

Insights from long‑term data sets showcase practical lessons for designing robust viral clearance strategies, validating new technologies, and anticipating where process adjustments may influence LRV outcomes. For organizations evaluating updates to their downstream platforms or looking to strengthen justification packages, this discussion provides grounded, evidence‑based guidance.

Access the full webinar to explore the decade‑long dataset, technology comparisons, and key takeaways for optimizing viral clearance performance.